Multimodal Image Analysis and Guidance of Neuromodulation for Trauma-Related Symptoms

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorUniversity of New Mexico

About this trial

MAGNETS is a prospective, randomized, parallel-design, sham-controlled clinical trial of accelerated, functional magnetic resonance imaging (fMRI)-guided intermittent theta burst stimulation (iTBS) to the right dorsolateral prefrontal cortex (dlPFC) for chronic symptoms of posttraumatic stress disorder (PTSD) in a comorbid Veteran population.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

are aged 18-80;

have a documented diagnosis of PTSD with evidence of ongoing symptoms as demonstrated by score of "31" or higher on the PCL-5, a measure of posttraumatic stress symptoms;

are fluent in English (as the neuropsychological testing tools used are only available in English) and

have been on stable doses of psychotropic medications for the past month.

Disqualifiers

a prior history of other neurological disease beyond mild TBI, as determined by VA/DoD criteria for TBI severity;

any history of seizures beyond immediate posttraumatic seizure or childhood febrile seizure, so as to reduce risk of exacerbation of epilepsy or other neurological symptoms;

history of a psychotic disorder, such as schizophrenia or bipolar disorder, so as to reduce risk of psychiatric decompensation;

active substance/alcohol dependence without ongoing treatment, to reduce confounding effects on diagnosis and brain imaging;

Trial design

Design model

Parallel

Treatments tested in this trial

  • Active Intermittent theta burst stimulation

    Device

    Intermittent theta burst stimulation (iTBS) is an efficient form of transcranial magnetic stimulation that allows up to 10x more pulses to be delivered in a given timeframe compared to conventional stimulation patterns.

  • Sham Intermittent theta burst stimulation

    Device

    Intermittent theta burst stimulation (iTBS) is an efficient form of transcranial magnetic stimulation that allows up to 10x more pulses to be delivered in a given timeframe compared to conventional stimulation patterns.

Treatment groups

64 Participants
are divided into 2 treatment groups
Group A: Active iTBSActive comparator 1 intervention
Group B: Sham iTBSSham comparator 1 intervention

Trial outcomes

Primary outcomes

1

CAPS-5

Clinician Administered PTSD Scale-DSM 5 (range 0-80; higher scores = more symptoms)

Time frame
Immediate post-treatment visit

Secondary outcomes

1

PCL-5

PTSD Checklist-DSM 5 (range 0-80; higher scores = more symptoms)

Time frame
Immediate post-treatment visit, 1 month, 3 months, 6 months
2

PHQ-9

Patient Health Questionnaire-9 (range 0-27; higher scores = more symptoms)

Time frame
Immediate post-treatment visit, 1 month, 3 months, 6 months
3

GAD-7

Generalized Anxiety Disorder-7 (range 0-21; higher scores = more symptoms)

Time frame
Immediate post-treatment visit, 1 month, 3 months, 6 months
4

NSI

Neurobehavioral Symptom Inventory (range 0-88; higher scores = more symptoms)

Time frame
Immediate post-treatment visit, 1 month, 3 months, 6 months

Other outcomes

1

AIM

Acceptability of Intervention Measure, a four-item measure of the acceptability of an intervention. It has five questions, scored on a 5-point Likert scale, from "completely disagree" to "completely agree"

Time frame
Immediate post-treatment visit
2

fMRI Connectivity

Connectivity between the dlPFC and vmPFC (range -1.0 to 1.0; higher scores indicate greater degree of positive correlation

Time frame
Immediate post-treatment visit

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of New Mexico

Lead sponsor

New Mexico VA Healthcare System

Collaborator